Melnikov M V, Sviridova A A, Rogovskii V S, Boyko A N, Pashenkov M V
Federal Center of Brain research and Neurotechnology, Moscow, Russia.
Pirogov Russian National Research Medical University, Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(5):51-56. doi: 10.17116/jnevro202212205151.
Multiple sclerosis (MS) is a chronic demyelinating and neurodegenerative disease of the central nervous system with an autoimmune mechanism of development. It is known that along with T- and B-lymphocytes, cells of the innate immune system also play a significant role in the pathogenesis of MS. Macrophages are central to the functioning of the innate immune response and, depending on the phenotype, have pro-and anti-inflammatory properties. In the central nervous system, resident macrophages form microglia capable of presenting antigens and producing cytokines and, depending on phenotype, may participate in the development of autoimmune inflammation or maintaining immunological tolerance. The brief report presents data on the participation of macrophages in the pathogenesis of experimental autoimmune encephalomyelitis and MS. In addition, current methods of modulation of macrophage functions for the treatment of MS are discussed.
多发性硬化症(MS)是一种中枢神经系统的慢性脱髓鞘和神经退行性疾病,其发病机制为自身免疫。已知除了T淋巴细胞和B淋巴细胞外,固有免疫系统的细胞在MS的发病机制中也发挥着重要作用。巨噬细胞是固有免疫反应功能的核心,根据其表型具有促炎和抗炎特性。在中枢神经系统中,常驻巨噬细胞形成能够呈递抗原和产生细胞因子的小胶质细胞,根据表型,可能参与自身免疫性炎症的发展或维持免疫耐受。本简要报告介绍了巨噬细胞参与实验性自身免疫性脑脊髓炎和MS发病机制的数据。此外,还讨论了目前调节巨噬细胞功能以治疗MS的方法。